Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Attana implements organizational changes and accelerates the development of Attana Diagnostics with COVID-19 tests leading the way

Attana can today announce that the company has strengthened its collaboration with the Linnaeus University to accelerate the development of unique antibody tests for COVID-19. Furthermore, the company moves forward with the regulatory efforts for AVA™ and implements a number of organizational changes aimed to establish an expert team leading the diagnostics initiative independent of Attana's ongoing operations.Strengthened collaboration with the Linnaeus UniversityThe Linnaeus University in Kalmar installed its first Attana instrument as early as 2003, and in 2019 the university was

New preclinical study confirms that Sepranolone suppresses tics in Tourette Syndrome

(Stockholm, 11 February 2021.) Two sets of new preclinical data presented by Prof Marco Bortolato (Univ. of Utah) confirm that Sepranolone suppresses tics in Tourette Syndrome (TS) and restores Prepulse Inhibition (PPI), a key phenomenon related to TS with no observable side-effects. The new data also point towards the overproduction of Allopregnanolone in acute stress situations as potentially crucial in triggering negative symptoms in neuropsychiatric conditions from Tourette to OCD, mania and schizophrenia.Professor Marco Bortolato presented the new preclinical findings at the “

Saga Pure ASA: Invitation to Webcast of Q4 2020 results on 17 February 2021 at 8:00 am (CET)

In connection with the release of the results for Q4 2020, Saga Pure ASA invites to the following event: Wednesday 17 February 2021 at 08.00 CET Live webcast of company Q4 update with Q&A. The Q4 Report and Presentation will be available at www.saga-pure.com and by a stock exchange release from Saga Pure ASA 17 February 2021. As a consequence of the Covid-19 pandemic, there will not be a physical presentation of the results. Link to webcast: https://channel.royalcast.com/landingpage/hegnarmedia/20210217_2/ For further information, please contact: Bjørn Simonsen, CEO, +47 97

Contemplated sale of shares in Kambi Group Plc

11 February 2021 THIS PRESS RELEASE IS FOR THE USE OF THE INTENDED RECIPIENT ONLY AND SHOULD NOT BE COPIED OR DISTRIBUTED TO ANY OTHER PERSON. NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WHOLLY OR PARTLY, IN OR INTO THE U.S. (OR TO U.S.PERSONS) ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER U.S. SECURITIES ACT OF 1933, AS AMENDED, OR IN ANY OTHER JURISDICTION IF SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF APPLICABLE SECURITIES LAWS. PLEASE REFER TO THE SECTION "IMPORTANT INFORMATION" AT

VALMET Oyj: ACQUISITION OF OWN SHARES 11.02.2021

Valmet Oyj NOTIFICATION 11.02.2021 at 18:30 VALMET Oyj: ACQUISITION OF OWN SHARES 11.02.2021 Date 11.02.2021Exchange transaction BuyShare class VALMTAmount 32,333Average price/share 27.5484 EURHighest price/share 27.8500 EURLowest price/share 27.1500 EURTotal price 890,722.42 EUR The shares held by Valmet Oyj on 11.02.2021: VALMT 438,270   On behalf of Valmet Oyj  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Janne Tiihonen For more information, please

Orkla ASA: Mandatory notification of trade and disclosure of major shareholding - Stein Erik Hagen

On 11 February 2021, Canica AS, a company related to Orkla's chairman of the board Stein Erik Hagen, acquired 286,000 shares in Orkla ASA over Oslo Stock Exchange. Following the transaction, Stein Erik Hagen and related parties’ ownership interest in Orkla ASA is 250,386,000 shares, constituting approx. 25,003% of the share capital of the company. Thus, Hagen and related parties crosses the 25% threshold for disclosure of major shareholding. The transaction was made at a share price of NOK 80.7663.   Orkla ASA Oslo, 11 February 2021 Ref.: Investor Relations Kari Lindtvedt Tel.

Spa Holdings 3 Oy to commence redemption proceedings in respect of the remaining minority shares in Ahlstrom-Munksjö Oy

AHLSTROM-MUNKSJÖ OYJ    STOCK EXCHANGE RELEASE  February 11, 2021 at 18:15 EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. On January 20, 2021, Spa Holdings 3 Oy (the “Offeror”) announced that it will complete the voluntary public cash tender offer to acquire all of the issued and outstanding shares in Ahlstrom-Munksjö Oyj (“Ahlstrom-Munksjö” or the “Company”) that are

Paradox Insider Returns on March 13

Paradox Interactive Partners with The MIX to Share News, Updates, and Inside Scoops on Upcoming Games via Twitch BroadcastSTOCKHOLM - Feb. 11, 2021 - Paradox Interactive, a publisher and developer of games with a lot of inside jokes, today announced that Paradox Insider, the online presentation of news and updates about its upcoming catalogue of games, will appear once again on March 13, 2021.  Paradox Insider will be part of Game Dev Direct, a digital event  presented by The Media Indie Exchange (The MIX), on Twitch at 9:00 a.m. Pacific (18:00 CET), with Paradox Insider going live at 11:

#21-57 Change of last day of trading on Bond at NGM

Sätra Förvaltnings AB has published a press release stating that the last day of trading will be changed to 2022-02-18 for Bond Satra 2 with ISIN SE0012740918.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in

#21-56 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-55 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Storebrand ASA - Status share buy back to fund employee incentive program

Storebrand ASA has on 11 February purchased 140,324 own shares at an average price of NOK 71.18 per share. After this transaction Storebrand owns a total of 556,579 own shares. For further information about the programme Storebrand refers to the Oslo Stock Exchange notification made on 11 February 2021 . Lysaker, 11 February 2021 Contacts Head of Investor Relations, Sundahl, Daniel daniel.sundahl@storebrand.no or (+47) 913 61 899 Storebrand's ambition is to provide our customers with financial freedom and security by being the best

Update regarding the approval process of Actiste Mini in UAE

The market approval process for Actiste Mini as a medical device in the United Arab Emirates is, as previously stated, underway. Step one out of three has been completed (the three steps being 1. Classification stage, 2. Product registration stage, and 3. Manufacturing stage). Brighter will commence the second step shortly. Since the manufacturing phase has already been completed during the Actiste registration earlier, Actiste Mini will hopefully be granted registration in the country shortly after completion of the second step of the process. For further information, please contact:

Pexip delivers strong revenue growth and solid profitability in Q4 2020

Oslo, Norway, 11 February 2021 - The video communications provider, Pexip, today presented its quarterly results for the fourth quarter and full year 2020.Q4 2020  Pexip's subscription base measured in Annual Recurring Revenue (ARR) reached USD 81.9 million in Q4 2020, up from USD 47.2 million in Q4 2019, representing an increase of 73%. The growth was driven by a range of important customer wins both in the enterprise segment and in the public sector, such as a record deal with the US Defense Health Agency at approximately USD 2 million in ARR. At the same time the percent of retained

J.P. Morgan Chase & Co.’s indirect holding in Tikkurila increased above 5 percent

Tikkurila OyjMajor Shareholders Announcement11 February 2021 at 5.30 (EET) Tikkurila Oyj (business ID 0197067-4) has on February 11, 2021, received a notification pursuant to the Finnish Securities Markets Act, Chapter 9, Section 10, from J.P. Morgan Chase & Co. The indirect holding of the funds and accounts managed by J.P. Morgan Chase & Co. in the shares and financial instruments of Tikkurila Oyj has increased above 5% threshold, as a consequence of the trades executed on February 8, 2021. J.P. Morgan Chase & Co.’s position according to their notification: Full name of

CORRECTION: Managers’ transactions – Smith

Nordea Bank AbpStock exchange release – Managers’ transactions11 February 2021 at 17.30 EET Transaction notification under Article 19 of the EU Market Abuse RegulationCorrection to Nordea Bank Abp’s stock exchange release regarding managers’ transactions on 11 February 2021. Due to a technical error, the price information was misreported. Below is the corrected notification. Person subject to the notification requirementName: SMITH, IANPosition: Chief Financial OfficerIssuer: Nordea Bank AbpLEI: 529900ODI3047E2LIV03  Notification type: AMENDMENTReference number:

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release February 11, 2021, at 5:25 p.m. Nokian Tyres has received an announcement from BlackRock, Inc. on February 11, 2021, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement BlackRock, Inc.'s total holding in Nokian Tyres shares exceeded the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on February 10, 2021. BlackRock, Inc. and its funds held on deal date a total of 7,095,348 Nokian Tyres’ shares representing 5.10% of the company’s 138,921,750

The divestment of Collector Ventures has been completed

On 10 September 2020 Collector AB (“Collector”) entered into an agreement to divest its entire holding in Collector Ventures 1 Kommanditbolag (“Collector Ventures”), which manages Collector’s investment business focusing on fintech, to NFT Ventures for SEK 330 million on a cash and debt free basis. The transaction required approval from the Swedish Financial Supervisory Authority which now has been granted and the transaction has been completed.Collector Ventures was founded jointly with NFT Ventures in 2016 with the purpose of making investments in fintech companies. Since its

Enzymatica comments on article in Dagens Medicin

Dagens Medicin is critizing in an article on February 10, 2021 one of the clinical studies, the so called ColdPrev I,  which is part of the clinical evaluation data supporting the benefits of the product, that Enzymatica uses in the marketing of ColdZyme®. Enzymatica refuses the criticism and gives the comment below.ColdZyme is a very well-documented product, whose effect on common cold has been verified in both in vitro studies as well as in vivo studies. An in vitro study from 2017 showed that ColdZyme could deactivate over 90% of the known viruses that cause common colds. The ColdPrev I

Issue and repurchase of class C shares under incentive program

The board of directors of Bravida Holding AB, (“Bravida”), (Nasdaq Stockholm: BRAV), has today resolved to issue and immediately thereafter repurchase 500,000 class C shares.By virtue of authorization from the extraordinary general meeting on 23 October 2020, the board of directors of Bravida has resolved to increase the share capital by SEK 10,000 through a directed cash issue of 500,000 class C shares to Nordea Bank Abp, filial i Sverige (“Nordea”) at a subscription price corresponding to the quota value of the shares. Furthermore, the board of directors of Bravida has resolved to

Proposal by the Nomination Committee of AQ Group AB for election of the Board of Directors

AQ Group's Nomination Committee consists of Claes Mellgren, Björn Henriksson, representing Nordea Fonder, Hans Christian Bratterud, representing ODIN Fonder and the Chairman of the Nomination Committee Per-Olof Andersson. In accordance with the Annual General Meeting's decision, the Nomination Committee shall evaluate the composition and work of the Board and prepare proposals for the Annual General Meeting in 2021. The Nomination Committee has evaluated the work of the Board and the Chairman of the Board has described how the work has been conducted. The Nomination Committee has also

There are no items matching the current filter
There are no more items matching the current filter
Back to top